BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7267377)

  • 1. [Selected problems concerning the treatment of proliferative syndromes of the hemopoietic system].
    Polubiec A
    Pol Arch Med Wewn; 1981 Apr; 65(4):257-65. PubMed ID: 7267377
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental and selected clinical aspects of active immunotherapy in leukemia].
    Luczyński W; Krawczuk-Rybak M; Stasiak-Barmuta A
    Postepy Hig Med Dosw (Online); 2006; 60():379-86. PubMed ID: 16885908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some implications of current therapy in leukaemia.
    Jacobs P
    S Afr Med J; 1974 Aug; 48(37):1573-6. PubMed ID: 4527979
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the thymus and thymic humoral factors in immunotherapy of aplastic and proliferative diseases of the hemopoietic system.
    Aleksandrowicz J; Skotnicki AB
    Acta Med Pol; 1976; 17(1):1-17. PubMed ID: 769487
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible application of natural killer cells and interleukin-2 in therapy of human leukemia.
    Lotzová E
    Prog Clin Biol Res; 1987; 244():259-66. PubMed ID: 3498951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proliferative capacity in acute leukemia after treatment with antiblastics].
    Gabutti V; Pileri A; Rovera G; Tarocco RP; Gavosto F
    Boll Soc Ital Biol Sper; 1967 Feb; 43(4):191-5. PubMed ID: 6055644
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of neoplasms of the hematopoietic system based on some principles of cytokinetics].
    Traczyk Z
    Acta Haematol Pol; 1974; 5(1):85-90. PubMed ID: 4595062
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of immunotherapy in acute parablastic leukosis].
    Aurich G; Plenert W; Zintl F; Polzin G; Blau HJ; Kruse H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):21-8. PubMed ID: 4104079
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antimitotic chemotherapy and proliferative activity of leukemic cells].
    Astaldi G; Meardi G
    Minerva Med; 1966 Mar; 57(25):1094-6. PubMed ID: 5932009
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy and proliferative potentiality of the leukemic elements].
    Dogliotti GC; Pileri A
    Minerva Med; 1966 Mar; 57(25):1086-90. PubMed ID: 5932007
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems of the immunotherapy of malignant neoplasma].
    Trapeznikov NN; Iavorskiĭ VV
    Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy in leukemia. Experimental and clinical approaches.
    Mathé G
    Ser Haematol; 1972; 5(5):66-86. PubMed ID: 4151467
    [No Abstract]   [Full Text] [Related]  

  • 13. [An attempt of immunological stimulation of patients with proliferative and applastic diseases of the haematopoietic system by means of calf's thymus extract (TFX) (author's transl)].
    Aleksandrowicz J; Szmigiel Z; Czarnecki J; Turowski G; Skotnicki AB
    Przegl Lek; 1975; 32(2):277-9. PubMed ID: 1167699
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pro and con: Immunotherapy in acute leukemia. Arguments for immunotherapy].
    Büchner T; Urbanitz D
    Internist (Berl); 1980 Jul; 21(7):362-6. PubMed ID: 7007269
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of whole-body hyperthermia in the treatment of neoplastic disease: its current status and future prospects.
    Robins HI
    Cancer Res; 1984 Oct; 44(10 Suppl):4878s-4883s. PubMed ID: 6467241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pro and con: Immunotherapy in acute leukemia. Arguments against immunotherapy].
    Hirschmann WD
    Internist (Berl); 1980 Jul; 21(7):367-70. PubMed ID: 7007270
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy for acute leukemia.
    Boyiadzis M; Whiteside TL; Pavletic SZ
    Aging (Albany NY); 2015 Jun; 7(6):354-5. PubMed ID: 26143183
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy of neoplasms with special consideration of leukemia].
    Kotlarek-Haus S
    Pol Arch Med Wewn; 1979 Aug; 62(2):127-35. PubMed ID: 503893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Present state of immunotherapy of tumours (author's transl)].
    Rieche K
    Arch Geschwulstforsch; 1974; 44(2):167-81. PubMed ID: 4375452
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted cellular immunotherapy for leukemia patients.
    Casalegno-Garduño R; Schmitt A; Wang X; Xu X; Schmitt M
    Transfus Apher Sci; 2010 Oct; 43(2):207-10. PubMed ID: 20678962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.